Prognostic analysis and development of a prognostic model for EML4-ALK-positive lung cancer patients treated with ALK-TKIs. [PDF]
Front Med (Lausanne)Liu R, Su C, Su H, Wang L.
europepmc +1 more source
Analysis of influencing factors of recurrence after thoracoscopic resection in patients with Stage I a lung adenocarcinoma. [PDF]
Am J Cancer ResWei RS +5 more
europepmc +1 more source
Clinical Characteristics and Development of a Risk-Identification Model for Incidentally Detected Cancer in Patients with Diabetes: A Case-Control Study. [PDF]
Diabetes Metab Syndr ObesCheang N, Chen X, Zhang H, Su Q, Du S.
europepmc +1 more source
Analysis of the value of CEA, NSE, CYFRA21-1 and other lung cancer markers
Asian Journal of SurgeryShipin Zhao +3 more
openaire +1 more source
A composite immune-nutritional and tumor marker score predicts outcomes in LA-ESCC treated with neoadjuvant chemoimmunotherapy and surgery. [PDF]
Discov OncolFan Y +5 more
europepmc +1 more source
Related searches:
The diagnostic efficacy of CYFRA21-1 on intrahepatic cholangiocarcinoma: A meta-analysis
Clinics and Research in Hepatology and Gastroenterology, 2019To evaluate the reliability and accuracy of Cytokeratin-19-fragment (CYFRA21-1) in the diagnosis of intrahepatic cholangiocarcinoma (ICC) based on literature meta-analysis and the diagnostic efficacy and clinical application of CYFRA21-1 in ICC.MEDLINE, China National Knowledge Infrastructure Library and other databases were used to base the inclusion ...
He, Guowei +6 more
exaly +3 more sources
Serum CYFRA21-1 as a prognostic marker for patients with undifferentiated nasopharyngeal carcinoma
Biomarkers, 2010The purpose of this study was to evaluate the potential of serum CYFRA21-1 and carcinoembryonic antigen (CEA) as prognostic markers in patients with undifferentiated nasopharyngeal carcinoma. Sixty-one patients who received definitive radiotherapy/chemoradiotherapy were analysed retrospectively.
Wan-Qi, Zhu +4 more
exaly +3 more sources
Electrochemiluminescent immunoassay for the lung cancer biomarker CYFRA21-1 using MoOx quantum dots
Mikrochimica Acta, 2019Molybdenum oxide quantum dots (MoOx QDs) were synthesized by a one-pot method and used as a versatile probe in an electrochemiluminescent (ECL) immunoassay of the non-small cell lung cancer biomarker cytokeratin 19 fragment 21-1 (CYFRA21-1) as a model analyte. The MoOx QDs exhibited stable and strong cathodic green ECL, with an emission peak at 535 nm,
Wei Zheng, Hao-Hua Deng, Wei Chen
exaly +3 more sources
Multimodality therapy and significance of serum CYFRA21-1 for thymic carcinoma
Oncology Reports, 2005Thymic carcinoma is a rare mediastinal neoplasm with a poor prognosis due to delayed diagnosis and highly malignant behavior. To evaluate 7 serum tumor markers and the outcome of treatment, 11 stage III-IVb thymic carcinomas undergoing multimodality treatment were reviewed. High levels of serum CYFRA21-1 were detected in 5 patients (45%) and correlated
Makoto, Suzuki +4 more
openaire +2 more sources
This study was designed to develop a immunofluorescence chromatography kit for detection of CYFRA21-1 in human serum, and to evaluate the method performance. The fluorescent polystyrene particle conjugated with the monoclonal antibody MIC07 was used as a fluorescent label.
Lin Xia, Jiakun Cao, Sheng Tang
openaire +1 more source